www.fdanews.com/articles/150491-pharma-blog-watch
Pharma Blog Watch
October 25, 2012
Advocates Seek Equality Policies for Drug Costs (Pharmalot Blog)
“A group of non-profits has asked the NIH to grant a so-called march-in petition that would allow them to make and sell the Norvir HIV medication sold by Abbott Laboratories,” blogger Ed Silverman writes. Because of federal funding for the drug’s research and lower costs outside the U.S., petitioners are asking the NIH to set a policy that would grant march-in requests when U.S. residents face substantially higher prices than the patent owners charge in other countries with comparable incomes, Silverman adds.
“A group of non-profits has asked the NIH to grant a so-called march-in petition that would allow them to make and sell the Norvir HIV medication sold by Abbott Laboratories,” blogger Ed Silverman writes. Because of federal funding for the drug’s research and lower costs outside the U.S., petitioners are asking the NIH to set a policy that would grant march-in requests when U.S. residents face substantially higher prices than the patent owners charge in other countries with comparable incomes, Silverman adds.